Medicinal Cannabis in the management of ADHD: challenges faced.

• Autor(a) principal: Lemos Schuler, Maria Fernanda de
• Data de Publicação: 2023
• Outros Autores: Vasconcel, Aline Marinho, de Morais Manso, Pedro Henrique, Venâncio Brito, Leandro, Melo Assunção, Gabriel Nunes, Ramos, Arthur Souto, Costa da Silva, Teresa Victória, de Aquino Queiroz, Ana Júlia, Santos da Silva, Maria Cecília, Carvalho Viana, Igor, Ferreira da Silva, Emanuelly, Palhares Gomes, Bruna Luísa, Maia Fazoli, Karen, Dos Santos, Alencar Pereira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/613
• topic: TDAH; Cannabis; Transtorno; Hiperatividade; ADHD; Cannabis; Disorder; Hyperactivity

INTRODUCTION: Attention deficit hyperactivity disorder is a disease characterized by lack of concentration, hyperactivity and impulsivity and disorganization. Treated through medication therapy and psychotherapy. OBJECTIVES: Address the challenges faced by patients with ADHD who use cannabis. METHODS: Integrative review, carried out based on the guiding question: "What are the main challenges faced by medicinal cannabis in people with Attention Deficit Hyperactivity Disorder?", through articles in Portuguese and English, published between 2018 and 2023, originating from the MEDLINE, HomeoIndex, IBECS databases. Data collection took place in September 2023 RESULTS: The sample consisted of 7 articles, which denoted two nuclei: Self-medication and related difficulties in individuals diagnosed with ADHD; Medicinal Cannabis and challenges faced. CONCLUSION: It is understood that there is a lack of research related to the subject addressed, which is why many patients resort to the use of cannabis, which is why early identification of the disease is necessary, in order to be able to treat it in the best possible way. way, with proven scientific methods.